Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2.

Nishi, Kensuke; Yoshimoto, Shohei; Nishi, Soichiro; Tsunoda, Toshiyuki; Ohno, Jun; Yoshimura, Michinobu; Hiromatsu, Kenji; Yamano, Takafumi

Nishi, Kensuke; Yoshimoto, Shohei; Nishi, Soichiro; Tsunoda, Toshiyuki; Ohno, Jun; Yoshimura, Michinobu; Hiromatsu, Kenji; Yamano, Takafumi.

Afiliação

Nishi K; Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan; knishi@college.fdcnet.ac.jp.
Yoshimoto S; Nishi Otolaryngology Clinic, Fukuoka, Japan.
Nishi S; Section of Pathology, Department of Morphological Biology, Division of Biomedical Sciences, Fukuoka Dental College, Fukuoka, Japan.
Tsunoda T; Nishi Otolaryngology Clinic, Fukuoka, Japan.
Ohno J; Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Yoshimura M; Research Center for Regenerative Medicine, Fukuoka Dental College, Fukuoka, Japan.
Hiromatsu K; Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Yamano T; Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

In Vivo ; 36(1): 371-374, 2022.

Article em En | MEDLINE | ID: mdl-34972736

Assuntos

COVID-19; SARS-CoV-2; Enzima de Conversão de Angiotensina 2; Humanos; Japão; Peptidil Dipeptidase A/genética; Serina Endopeptidases; Internalização do Vírus

Palavras-chave

ACE2; EAT; Epipharyngeal abrasive therapy; SARS-CoV-2; TMPRSS2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: In Vivo Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de publicação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google